Healthcare and Pharmaceuticals industry

Global Pet Cancer Therapeutics Market Size Share Forecast 2024




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

The pet cancer therapeutics include chemotherapy drugs, targeted therapies, combination therapies, and immunotherapy vaccines, which are commonly recommended by the veterinary doctors. The drugs are mostly recommended to treat various conditions such as lymphoma, mast cell tumors, fibrosarcoma, hemangiosarcoma, and others. Currently, a wide range of formulations are available in the global market for the treatment of pet cancers, which can be administered in the form of tablets, injections or can be applied topically. Thus, the large variety of treatment options has made it easy for the pets to receive effective cancer treatment suitable to curb the condition.
Market Dynamics
The major factor driving growth of the pet cancer therapeutics market include robust number of pipeline drugs for the treatment of highly prevalent conditions such as lymphoma and melanoma. For instance, in 2017, Aratana Therapeutics received approval from the United States Department of Agriculture (USDA) Center for Veterinary Biologics for canine osteosarcoma vaccine- AT-014 for the treatment of dogs diagnosed with osteosarcoma, one year of age or older. The drug candidate was licensed exclusively from Advaxis, Inc. and is currently in the pivotal trial. Moreover, the private and government organizations such as Veterinary Cancer Society, Petco Foundation, and Animal Cancer Foundation are working together to formulate novel drugs for dogs and cats, which is a major factor expected to propel growth of the pet cancer therapeutics market over the forecast period. However, lack of awareness regarding pet diseases, high cost, and adverse effects of the drugs are the factors restraining pet cancer therapeutics market growth.
Key features of the study:

This report provides in-depth analysis of pet cancer therapeutics market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2017 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global pet cancer therapeutics market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Aratana Therapeutics, Inc., AB Science, Boehringer Ingelheim International GmbH, Zenoaq, Morphogenesis, Inc., VetDC, Inc., Karyopharm Therapeutics, Inc., Rhizen Pharmaceuticals SA, Regeneus Ltd., Oasmia Pharmaceuticals AB, and Zoetis
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global pet cancer therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the pet cancer therapeutics market

Detailed Segmentation:

Global Pet Cancer Therapeutics Market, By Therapy Type:

Chemotherapy
Targeted Therapy
Combination Therapy
Immunotherapy

Global Pet Cancer Therapeutics Market, By Pet Type:

Cat
Dog
Horse

Global Pet Cancer Therapeutics Market, By Mode of Administration:

Oral
Intravenous
Topical

Global Pet Cancer Therapeutics Market, By Application:

Lymphoma
Mast Cell Cancer
Melanoma
Mammary and Squamous Cell Cancer
Others

Global Pet Cancer Therapeutics Market, By Geography:

North America

By Therapy Type:

Chemotherapy
Targeted Therapy
Combination Therapy
Immunotherapy

By Pet Type:

Cat
Dog
Horse

By Mode of Administration:

Oral
Intravenous
Topical

By Application:

Lymphoma
Mast Cell Cancer
Melanoma
Mammary and Squamous Cell Cancer
Others

By Country:

U.S.
Canada


Latin America

By Therapy Type:

Chemotherapy
Targeted Therapy
Combination Therapy
Immunotherapy

By Pet Type:

Cat
Dog
Horse

By Mode of Administration:

Oral
Intravenous
Topical

By Application:

Lymphoma
Mast Cell Cancer
Melanoma
Mammary and Squamous Cell Cancer
Others

By Country:

Brazil
Mexico
Argentina
Rest of Latin America


Europe

By Therapy Type:

Chemotherapy
Targeted Therapy
Combination Therapy
Immunotherapy

By Pet Type:

Cat
Dog
Horse

By Mode of Administration:

Oral
Intravenous
Topical

By Application:

Lymphoma
Mast Cell Cancer
Melanoma
Mammary and Squamous Cell Cancer
Others

By Country:

Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe


Asia Pacific

By Therapy Type:

Chemotherapy
Targeted Therapy
Combination Therapy
Immunotherapy

By Pet Type:

Cat
Dog
Horse

By Mode of Administration:

Oral
Intravenous
Topical

By Application:

Lymphoma
Mast Cell Cancer
Melanoma
Mammary and Squamous Cell Cancer
Others

By Country:

China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific


Middle East

By Therapy Type:

Chemotherapy
Targeted Therapy
Combination Therapy
Immunotherapy

By Pet Type:

Cat
Dog
Horse

By Mode of Administration:

Oral
Intravenous
Topical

By Application:

Lymphoma
Mast Cell Cancer
Melanoma
Mammary and Squamous Cell Cancer
Others

By Country:

GCC
Israel
Rest of Middle East


Africa

By Therapy Type:

Chemotherapy
Targeted Therapy
Combination Therapy
Immunotherapy

By Pet Type:

Cat
Dog
Horse

By Mode of Administration:

Oral
Intravenous
Topical

By Application:

Lymphoma
Mast Cell Cancer
Melanoma
Mammary and Squamous Cell Cancer
Others

By Country:

South Africa
Central Africa
North Africa



Company Profiles

Aratana Therapeutics, Inc.*

Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments

AB Science
Boehringer Ingelheim International GmbH
Zenoaq
Morphogenesis, Inc.
VetDC, Inc.
Karyopharm Therapeutics, Inc.
Rhizen Pharmaceutical SA
Regeneus Ltd.
Oasmia Pharmaceuticals AB
Zoetis


 “*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet, By Therapy Type
? Market Snippet, By Pet Type
? Market Snippet, By Mode of Administration
? Market Snippet, By Application
? Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
o Key Highlights
o Pipeline Analysis
o Regulatory Guidelines
o Initiatives for Prevention of Pet Cancer
o Approved Targeted Therapies for Pet Cancer
o Epidemiology
4. Global Pet Cancer Therapeutics Market, By Therapy Type, 2017 - 2025, (US$ Million)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2017 - 2025
? Segment Trends
o Chemotherapy
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Targeted Therapy
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Combination Therapy
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Immunotherapy
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
5. Global Pet Cancer Therapeutics Market, By Pet Type, 2017 - 2025, (US$ Million)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2017 - 2025
? Segment Trends
o Cat
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Dog
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Horse
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
6. Global Pet Cancer Therapeutics Market, By Mode of Administration, 2017 - 2025, (US$ Million)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2017 - 2025
? Segment Trends
o Oral
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Intravenous
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Topical
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
7. Global Pet Cancer Therapeutics Market, By Application, 2017 - 2025, (US$ Million)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2017 - 2025
? Segment Trends
o Lymphoma
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Mast Cell Cancer
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Melanoma
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Mammary and Squamous Cell Cancer
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
o Others
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)
8. Global Pet Cancer Therapeutics Market, By Region, 2017 - 2025, (US$ Million)
o Introduction
? Market Share Analysis, By Region, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, For Regions, 2017 - 2025
o North America
? Market Size and Forecast, By Therapy Type, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Pet Type, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Mode of Administration, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
? U.S.
? Canada
o Latin America
? Market Size and Forecast, By Therapy Type, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Pet Type, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Mode of Administration, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
? Brazil
? Mexico
? Argentina
? Rest of Latin America
o Europe
? Market Size and Forecast, By Therapy Type, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Pet Type, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Mode of Administration, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
? Germany
? U.K.
? France
? Italy
? Spain
? Russia
? Rest of Europe
o Asia Pacific
? Market Size and Forecast, By Therapy Type, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Pet Type, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Mode of Administration, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
? China
? India
? Japan
? Australia
? South Korea
? ASEAN
? Rest of APAC
o Middle East
? Market Size and Forecast, By Therapy Type, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Pet Type, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Mode of Administration, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
? GCC
? Israel
? Rest of Middle East
o Africa
? Market Size and Forecast, By Therapy Type, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Pet Type, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Mode of Administration, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Application, 2017 - 2025, (US$ Million)
? Market Size and Forecast, By Country, 2017 - 2025, (US$ Million)
? South Africa
? Central Africa
? North Africa
9. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis (3x3 Matrix)
o Company Profiles
? Aratana Therapeutics, Inc.*
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? AB Science
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Boehringer Ingelheim International GmbH
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Zenoaq
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Morphogenesis, Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? VetDC, Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Karyopharm Therapeutics, Inc.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Rhizen Pharmaceuticals SA
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Regeneus Ltd.
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Oasmia Pharmaceuticals AB
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
? Zoetis
? Company Overview
? Product Portfolio
? Financial Performance
? Recent Developments/Updates
? Future Plans
?
o Analyst Views
10. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 55 market data tables and 45 figures on "Pet Cancer Therapeutics Market - Global forecast to 2025".

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.